Among these mutations, the glycine to serine substitution (G2019S), located within the protein kinase domain encoded by exon 41, is the most common and was estimated by the international LRRK2 consortium to represent 1% of sporadic and 4% of familial PD patients worldwide [9]. The gene discussed is LRRK2; the disease is Parkinson disease.